TY - JOUR
T1 - Mechanism of the Reaction Catalyzed by Mandelate Racemase
T2 - Structure and Mechanistic Properties of the K166R Mutant
AU - Kallarakal, Abraham T.
AU - Mitra, Bharati
AU - Kozarich, John W.
AU - Gerlt, John A.
AU - Clifton, James G.
AU - Petsko, Gregory A.
AU - Kenyon, George L.
PY - 1995/3
Y1 - 1995/3
N2 - On the basis of the available high-resolution structures of mandelate racemase (MR) from Pseudomonas putida [Landro, J. A., Gerlt, J. A., Kozarich, J. W., Koo, C. W., Shah, V. J., Kenyon, G. L., Neidhart, D. J., Fujita, J., & Petsko, G. A. (1994) Biochemistry 33, 635-643], Lys 166 and His 297 are positioned appropriately to participate in catalysis as acid/base catalysts that either abstract the a-proton from the enantiomers of mandelate to form an enolic intermediate or protonate the enolic intermediate to form the enantiomers of mandelate, with Lys 166 participating as the (S)-specific acid/base catalyst and His 297 participating as the (R)-specific acid/base catalyst. In this paper we report the structural and mechanistic properties of the mutant in which Lys 166 has been replaced with arginine (K166R). The structure of K166R has been determined at 1.85 A resolution with die substrate (S)-mandelate bound in the active site. The structure of this complex reveals no geometric alterations in the active site, with the exception that the longer side chain of Arg 166 is necessarily displaced upward from the position occupied by Lys 166 by steric interactions with the bound substrate. In contrast to the H297N mutant of MR [Landro, J. A., Kallarakal, A. T., Ransom, S. C., Gerlt, J. A., Kozarich, J. W., Neidhart, D. J., & Kenyon, G. L. (1991) Biochemistry 30, 9275-9281], the K166R exhibits low levels of racemase activity [kcat is reduced 5 x 103-fold in the (R)- to (S)-direction and 1 x 103-fold in the (S)- to (R)-direction], The substrate and solvent deuterium isotope effects support a reaction coordinate for the K166R-catalyzed reaction in which the transition state for interconversion of bound (S)-mandelate and the stabilized enolic intermediate is higher in energy that the transition state for interconversion of bound (R)-mandelate and the stabilized enolic intermediate. The solvent deuterium isotope effect when (S)-mandelate is substrate (2.2 ± 0.3) supports the proposal that the formation of the enolic intermediate involves partial transfer of a solvent-derived proton from Glu 317 to the substrate as the a-proton is abstracted [Mitra, B., Kallarakal, A. T., Kozarich, J. W., Gerlt, J. A., Clifton, J. G., Petsko, G. A., & Kenyon, G. L. (1995) Biochemistry 34, 2777-2787]. K166R catalyzes the stereospecific elimination of bromide ion from (R)-p-(bromomethyl)- mandelate to form p-(methyl)benzoylformate at a rate (0.012 s-1) that is similar to that catalyzed by wild-type MR (0.025 s-1) and H297N (0.012 s-1)> although the latter elimination is stereospecific for (S)-p-(bromomethyl)mandelate. The rate constant for the elimination reaction catalyzed by K166R suggests that the rate of interconversion of bound (R)-mandelate and the enolic intermediate is the same as that catalyzed by wild-type MR.
AB - On the basis of the available high-resolution structures of mandelate racemase (MR) from Pseudomonas putida [Landro, J. A., Gerlt, J. A., Kozarich, J. W., Koo, C. W., Shah, V. J., Kenyon, G. L., Neidhart, D. J., Fujita, J., & Petsko, G. A. (1994) Biochemistry 33, 635-643], Lys 166 and His 297 are positioned appropriately to participate in catalysis as acid/base catalysts that either abstract the a-proton from the enantiomers of mandelate to form an enolic intermediate or protonate the enolic intermediate to form the enantiomers of mandelate, with Lys 166 participating as the (S)-specific acid/base catalyst and His 297 participating as the (R)-specific acid/base catalyst. In this paper we report the structural and mechanistic properties of the mutant in which Lys 166 has been replaced with arginine (K166R). The structure of K166R has been determined at 1.85 A resolution with die substrate (S)-mandelate bound in the active site. The structure of this complex reveals no geometric alterations in the active site, with the exception that the longer side chain of Arg 166 is necessarily displaced upward from the position occupied by Lys 166 by steric interactions with the bound substrate. In contrast to the H297N mutant of MR [Landro, J. A., Kallarakal, A. T., Ransom, S. C., Gerlt, J. A., Kozarich, J. W., Neidhart, D. J., & Kenyon, G. L. (1991) Biochemistry 30, 9275-9281], the K166R exhibits low levels of racemase activity [kcat is reduced 5 x 103-fold in the (R)- to (S)-direction and 1 x 103-fold in the (S)- to (R)-direction], The substrate and solvent deuterium isotope effects support a reaction coordinate for the K166R-catalyzed reaction in which the transition state for interconversion of bound (S)-mandelate and the stabilized enolic intermediate is higher in energy that the transition state for interconversion of bound (R)-mandelate and the stabilized enolic intermediate. The solvent deuterium isotope effect when (S)-mandelate is substrate (2.2 ± 0.3) supports the proposal that the formation of the enolic intermediate involves partial transfer of a solvent-derived proton from Glu 317 to the substrate as the a-proton is abstracted [Mitra, B., Kallarakal, A. T., Kozarich, J. W., Gerlt, J. A., Clifton, J. G., Petsko, G. A., & Kenyon, G. L. (1995) Biochemistry 34, 2777-2787]. K166R catalyzes the stereospecific elimination of bromide ion from (R)-p-(bromomethyl)- mandelate to form p-(methyl)benzoylformate at a rate (0.012 s-1) that is similar to that catalyzed by wild-type MR (0.025 s-1) and H297N (0.012 s-1)> although the latter elimination is stereospecific for (S)-p-(bromomethyl)mandelate. The rate constant for the elimination reaction catalyzed by K166R suggests that the rate of interconversion of bound (R)-mandelate and the enolic intermediate is the same as that catalyzed by wild-type MR.
UR - http://www.scopus.com/inward/record.url?scp=0028901756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028901756&partnerID=8YFLogxK
U2 - 10.1021/bi00009a007
DO - 10.1021/bi00009a007
M3 - Article
C2 - 7893690
AN - SCOPUS:0028901756
SN - 0006-2960
VL - 34
SP - 2788
EP - 2797
JO - Biochemistry
JF - Biochemistry
IS - 9
ER -